AMERESCO INC-CL A
AMRCNYSE🏆 #2331 by market capEarnings Nov 9 · PostUS Equity
$20.31▲ $0.39 (+1.96%)
🌅 Pre-market$20.31▲ 0.00%Regular close · extended-hours price shownTrack AMRC
Get earnings, price moves & breaking news on Telegram
24h▲ 2.0%
7d▲ 6.6%
14d▲ 1.0%
30d▼ 3.7%
ytd▼ 30.5%
1y▼ 48.5%
🏦Market Cap
$1.08B
Small Cap
📈Revenue Growth (YoY)
8.9%
Slowing
📊Gross Margin
16.1%
Thin
💵FCF Margin
0.3%
Thin
⚖️P/S Ratio
0.5x
Cheap
Otter Score
56
Fair
AMERESCO INC-CL A
AMRCAnalyst Ratings
Price
$20.31
Total
24
Raised
4
Lowered
4
Avg PT
$44.67
H / L
$62 / $36
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Cantor Fitzgerald | Reiterated | Overweight | 2026-08-27 | $36.00 | +77.30% |
Baird | Downgraded | Outperform → Neutral | 2026-08-18 | — | — |
UBS | Reiterated | Neutral | 2026-08-05 | $40.00 | +96.90% |
Canaccord Genuity | Reiterated | Buy | 2026-08-04 | $62.00 | +205.30% |
BNP Paribas | Upgraded | Neutral → Outperform | 2026-08-04 | $40.00 | +96.90% |
Stifel | Reiterated | Buy | 2026-03-11 | — | — |
B. Riley Securities | Reiterated | Buy | 2026-03-04 | — | — |
Roth Capital | Reiterated | Buy | 2025-11-03 | $45.00 | +121.60% |
Jefferies | Upgraded | Hold → Buy | 2025-09-25 | $45.00 | +121.60% |
Piper Sandler | Reiterated | Overweight | 2025-05-06 | $21.00 | +3.40% |
Truist Securities | Reiterated | Buy | 2024-04-22 | — | — |
Oppenheimer | Reiterated | Perform | 2024-04-17 | — | — |
Raymond James | Reiterated | Outperform | 2024-04-03 | $40.00 | +96.90% |
Exane BNP Paribas | Upgraded | Neutral → Outperform | 2024-03-12 | — | — |
B of A Securities | Downgraded | Buy → Neutral | 2023-12-15 | — | — |
William Blair | Downgraded | Outperform → Market Perform | 2023-11-07 | — | — |
Roth MKM | Upgraded | Neutral → Buy | 2023-10-25 | — | — |
Craig-Hallum | Reiterated | Buy | 2023-08-01 | $82.00 | +303.70% |
EF Hutton | Reiterated | Buy | 2023-05-16 | $78.00 | +284.00% |
Guggenheim | Reiterated | Buy | 2021-01-29 | — | — |
B. Riley FBR | Reiterated | Buy | 2020-03-04 | — | — |
Northland Securities | Reiterated | Outperform | 2015-01-21 | — | — |
Barclays | Reiterated | Overweight | 2012-11-09 | — | — |
Wedbush | Downgraded | Outperform → Neutral | 2012-08-07 | — | — |
Institution
Cantor Fitzgerald
Reiterated · Overweight · 2026-08-27
$36.00
+77.30%
Baird
Downgraded · Outperform → Neutral · 2026-08-18
—
—
UBS
Reiterated · Neutral · 2026-08-05
$40.00
+96.90%
Canaccord Genuity
Reiterated · Buy · 2026-08-04
$62.00
+205.30%
BNP Paribas
Upgraded · Neutral → Outperform · 2026-08-04
$40.00
+96.90%
Stifel
Reiterated · Buy · 2026-03-11
—
—
B. Riley Securities
Reiterated · Buy · 2026-03-04
—
—
Roth Capital
Reiterated · Buy · 2025-11-03
$45.00
+121.60%
Jefferies
Upgraded · Hold → Buy · 2025-09-25
$45.00
+121.60%
Piper Sandler
Reiterated · Overweight · 2025-05-06
$21.00
+3.40%
Truist Securities
Reiterated · Buy · 2024-04-22
—
—
Oppenheimer
Reiterated · Perform · 2024-04-17
—
—
Raymond James
Reiterated · Outperform · 2024-04-03
$40.00
+96.90%
Exane BNP Paribas
Upgraded · Neutral → Outperform · 2024-03-12
—
—
B of A Securities
Downgraded · Buy → Neutral · 2023-12-15
—
—
William Blair
Downgraded · Outperform → Market Perform · 2023-11-07
—
—
Roth MKM
Upgraded · Neutral → Buy · 2023-10-25
—
—
Craig-Hallum
Reiterated · Buy · 2023-08-01
$82.00
+303.70%
EF Hutton
Reiterated · Buy · 2023-05-16
$78.00
+284.00%
Guggenheim
Reiterated · Buy · 2021-01-29
—
—
B. Riley FBR
Reiterated · Buy · 2020-03-04
—
—
Northland Securities
Reiterated · Outperform · 2015-01-21
—
—
Barclays
Reiterated · Overweight · 2012-11-09
—
—
Wedbush
Downgraded · Outperform → Neutral · 2012-08-07
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space